Universal Biosensors (ASX:UBI) said its major shareholder, Viburnum Funds, extended the due diligence period under the original term sheet for a proposed funding by a week to Aug. 15, according to a Thursday filing with the Australian bourse.
The companies are now exploring alternative structures, including a pro-rata entitlement offer to existing shareholders, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.